OPEN-LABEL TRIAL 开放性试验
In the safety study, a 52-week open-label trial, Dr. Wortzman and colleagues reported clindamycin-tretinoin gel to be safe and well tolerated in 655 patients (mean age, 20 years).
在52周的开放性安全试验中,Wortzman博士及其同事报告,655名患者(平均年龄20岁)使用克林霉素-维甲酸凝胶显示安全有效且耐受良好。
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
紫杉醇与S-1作为转移性乳腺癌的一线化疗(选择BC):一项开放标签、非劣效性、随机3期试验。
应用推荐